News

Boehringer Ingelheim study to assess safety and effectiveness of oral anticoagulants

BY Jason Owen

RIDGEFIELD, Conn. — Boehringer Ingelheim, a research-based, global pharmaceutical company, today announced a multi-year agreement with Brigham and Women’s Hospital on a long-term study program to assess comparative effectiveness and safety, as well as prescribing patterns, of oral anticoagulants, including Pradaxa, for the reduction of stroke risk in U.S. patients with non-valvular atrial fibrillation. Brigham and Women’s Hospital is an internationally recognized teaching affiliate of Harvard Medical School known for its excellence in patient care, medical research and training of outstanding young health professionals.

The objective of the study program is to better understand the real-world safety and effectiveness of warfarin and newer oral anticoagulants, including Pradaxa. Brigham and Women’s Hospital will analyze claims data from UnitedHealth Group’s research database, which is managed by one of the largest healthcare companies in the United States, serving more than 80 million individuals worldwide.

"It is our hope that the results of this study program will improve awareness that stroke risk related to NVAF is a growing public health issue and increase understanding of real-world experiences with new oral anticoagulants on the market to reduce stroke risk," said Sebastian Schneeweiss, vice chief, division of pharmacoepidemiology and pharmacoeconomics, Brigham and Women’s Hospital, and professor of medicine and epidemiology, Harvard Medical School. "This research will allow us to produce additional data over several years that will help the medical community and patients understand the risks and benefits of anticoagulants used to reduce the risk of stroke associated with non-valvular atrial fibrillation."

The study program demonstrates the commitment of Boehringer Ingelheim and Brigham and Women’s Hospital to research that analyzes real-world data to help enhance patient health and ensure patients with NVAF have additional information about treatments available to help reduce the risk of debilitating and potentially fatal strokes, the company stated. In addition to this study program, Boehringer Ingelheim launched the Gloriatm-AF registry program in April 2012, a worldwide registry with the aim of understanding the long-term use of OAC therapy in the reduction of NVAF-related stroke-risk in a real-world setting.

"Our support of the study program being conducted by Brigham and Women’s Hospital is a sign of our shared commitment to help improve healthcare delivery and outcomes for the estimated five million patients with non-valvular atrial fibrillation in the U.S. who are at increased risk for stroke," said Sabine Luik, M.D., senior vice president, medicine and regulatory affairs, U.S. regional medical director, Boehringer Ingelheim Pharmaceuticals, Inc. "As a science-based company, Boehringer Ingelheim considers patient safety and education as top priorities, and we remain dedicated to research and education which fosters greater public health."


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Bi-Lo, Winn-Dixie announce 10-week price freeze on hundreds of items

BY Jason Owen

GREENVILLE, S.C. and JACKSONVILLE, Fla. — Bi-Lo and its subsidiary Winn-Dixie announced on Thursday the companies will freeze prices over a 10-week period on hundreds of products across categories throughout its stores, starting with many items aimed at back-to-school shoppers.

“We are working hard to provide our customers the products they want at prices they can afford,” said Mary Kellmanson, Bi-Lo’s senior vice president of marketing. “Add a great selection of high-quality products, combined with extra attention to customer service, and we believe we’ve made shopping better and more affordable for our customers.”

The first wave of Price Locks coincide with back to school, not only helping customers save on every day grocery and household items, but helping get the family ready for school even easier and more affordable. Items frozen and offered at great prices for at least the next 10 weeks include Dove Soap, Ritz Crackers, Skippy Peanut Butter, Red Baron Pizza, Classico Pasta Sauce, Duncan Hines Brownies, Del Monte vegetables, Special K Bars, Scott Bath Tissue, Era Liquid Detergent, Oscar Meyer Selects, and Hormel Cooked Ham. Customers can learn more about Price Locks by visiting Bi-Lo.com.

In addition to Price Lock, Bi-Lo offers a comprehensive suite of savings programs, including the Bi-Lo Bonuscard and savings tied to its Fuelperks! fuel rewards program; $4/$10 generic pharmaceuticals; and weekly sales solutions including BOGOs, 10-for-$10s, Make-A-Meals, and What-A-Deals. Bi-Lo also offers eCoupons, a convenient way to load savings to Bi-Lo Bonuscard and have them redeemed automatically with a swipe of the card, right at the register.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

NCPA announces programming, features for 115th Annual Convention and Trade Exposition

BY Jason Owen

ALEXANDRIA, Va. — The National Community Pharmacists Association today announced the availability of the preliminary program and continuing education offerings for its 115th Annual Convention and Trade Exposition taking place Oct. 12 to 16, 2013, at the Walt Disney World Swan and Dolphin Resort in Orlando, Fla., as well as some special features of this year’s event.

“The heart and soul of NCPA’s convention are the innovative continuing education offerings and peer-to-peer networking that help independent community pharmacists remain competitive,” said NCPA president Donnie Calhoun, RPh, a pharmacy owner in Anniston, Ala. “Every year, pharmacists attending the meeting tell us they go home with an idea or tip to improve their business that more than paid for the cost of their trip.”

The meeting’s theme — Meet. Learn. Succeed. — is evidenced by many of the offerings. The 10-page Preliminary Program summarizes such key features as CE learning opportunities through “Success with Less Stress in the Pharmacy” with self-management expert Joy Baldridge, “Real World Marketing to Put Your Pharmacy on the Map” and “Audit Protection and Defense;” many chances to interact with vendors regarding new pharmacy solutions; general sessions, which include industry updates from NCPA leaders and remarks by President Bill Clinton; and events to socialize and further network, including an Opening Reception featuring Disney characters and a ticket to Walt Disney World Magic Kingdom Theme Park. New this year, the Exhibit Hall will open one day early, during the Opening Reception Saturday, Oct. 12, giving pharmacists an additional opportunity to explore vendors’ offerings.

NCPA has also published on its website the full schedule of 34 CE sessions for meeting attendees. In addition to the topics mentioned above, other CE sessions include “Fantastic Front-End Fixes,” “Complementary Niche Services,” “Establishing and Maintaining Your Social Media Presence” and “Compounding Status Update and Industry Forecast.”

In conjunction with the meeting, NCPA is also offering pre-convention programming sessions. To give community pharmacists a pathway toward accreditation and billing for diabetes self-management education/training services, the “Diabetes Accreditation Standards — Practical Applications (DASPA)” program will be held Oct. 10 to 11. To improve a pharmacy’s front-end offerings to increase store traffic and sales, NCPA is offering the “Front-End Profit Building Seminar” on Oct. 11 (the Aug. 26 session is sold out). In addition, the “Opportunities in Compounding” session on Oct. 12 will cover enhancing a pharmacy’s compounding practice through nutrition and pain management offerings. Plus, “1-Year, 5-Year, 10-Year Plan? A Valuable Prep Course for Selling Your Pharmacy” to help community pharmacy owners plan ahead for retirement will be held on Oct. 12.

Individuals interested in attending the convention can register online at ncpanet.org or by calling (800) 544-7447.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES